Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» oncology
oncology
Novartis oncology CEO Bruno Strigini is calling it quits
Endpoints
Fri, 12/15/17 - 10:09 am
Novartis
oncology
Bruno Strigini
Yervoy inventor’s oncology startup Pionyr gets $62M for tumor-fighting tech
Endpoints
Wed, 12/13/17 - 11:11 am
Yervoy
oncology
Pionyr
One big Novartis takeaway from Entresto's slow start? Heart failure doesn't work like oncology
Fierce Pharma
Wed, 11/29/17 - 11:40 am
Novartis
Entresto
drug launches
heart failure
oncology
Astellas innovation contest's second year yields bumper crop of creative cancer solutions
Fierce Pharma
Mon, 10/30/17 - 11:04 am
Astellas
innovation
oncology
Novartis to buy French cancer specialist AAA for $3.9 billion
Yahoo/Reuters
Mon, 10/30/17 - 09:58 am
Novartis
M&A
France
Advanced Accelerator Application
radiopharmaceuticals
oncology
[forum discussion]What's up in Oncology?
Cafepharma Message Boards
Wed, 10/11/17 - 09:59 am
Merck
oncology
drug reps
Lynparza
Most new cancer meds haven't proved they can improve or extend lives: study
Fierce Pharma
Thu, 10/5/17 - 09:38 am
cancer
oncology
Merck
Keytruda
Roche
Tecentriq
Ipsen focuses on oncology to keep growing
GoInPharma
Mon, 09/18/17 - 09:24 am
Ipsen
oncology
Xermelo
kidney cancer
Ramping back up on oncology, GSK takes an option on Adaptimmune’s TCR cancer drug
Endpoints
Thu, 09/7/17 - 09:41 am
GSK
oncology
Adaptimmune
TCR therapeutics
Jazz, ImmunoGen partner on hematology, oncology drug development
BioPharma Dive
Wed, 08/30/17 - 11:46 pm
Jazz Pharmaceuticals
Immunogen
oncology
hematology
drug development
New study of FDA cites the flaws behind rapid-fire cancer drug OKs
Endpoints
Wed, 08/16/17 - 11:14 am
FDA
drug approvals
cancer
oncology
Why Gilead Sciences Might Not Make an Oncology Acquisition
Motley Fool
Tue, 08/15/17 - 08:16 pm
Gilead Sciences
M&A
oncology
A Cancer Conundrum: Too Many Drug Trials, Too Few Patients
NY Times, NY
Mon, 08/14/17 - 09:30 pm
cancer
oncology
clinical trials
patients
Intas Pharmaceuticals offered $1.5bn for 3 divisions of Teva’s in Europe
GoInPharma
Mon, 08/14/17 - 10:04 am
Intas
India
M&A
Teva Pharmaceutical
Europe
Women's Health
oncology
pain management
Ending the era of $100,000 cancer drugs
Pharmafile
Sat, 08/12/17 - 12:08 pm
cancer
drug pricing
oncology
Teva sells as many as 4 assets: Medis, respiratory, women’s health and oncology
GoInPharma
Fri, 08/11/17 - 11:42 am
Teva Pharmaceutical
M&A
Respiratory
Women's Health
oncology
Medis
Sanofi believes it’s still not too late to become a top player in cancer drug market
Endpoints
Tue, 08/8/17 - 11:16 am
Sanofi
oncology
R&D
Takeda partners to develop novel oncology therapies
Drug Delivery Business News
Sat, 08/5/17 - 09:37 am
Takeda
Molecular Templates
Millenium
oncology
drug development
Bristol-Myers beefs up big cancer drug pipeline, buying IFM drugs in $2.3B-plus deal
Endpoints
Thu, 08/3/17 - 06:22 pm
Bristol-Myers Squibb
IFM Therapeutics
oncology
M&A
Lilly puts two-thirds of midphase cancer pipeline up for sale in major shake-up of R&D priorities
Fierce Biotech
Tue, 07/25/17 - 10:27 am
Eli Lilly
M&A
oncology
R&D
Pages
« first
‹ previous
…
17
18
19
20
21
22
23
24
25
…
next ›
last »